Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name SNHG16
   Synonyms SNHG16, Nbla10727, Nbla12061, ncRAN
   Region GRCh38_17:76557766-76565348    Sequence
   Ensembl ENSG00000163597
   RefSeq NR_038108
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name bladder cancer
   ICD-0-3 C67  
   Methods qPCR etc.
   Sample bladder cancer tissues, cell lines (RT4, T24, J82 etc.)
   Expression Pattern up-regulated
   Function Description

Expression of ncRAN was significantly higher in bladder cancers compared with normal tissues and in invasive tumor compared with superficial ones. Consistently, ncRAN expressed significantly higher in invasive bladder tumor cell lines (5637, T24, J82) than that in superficial tumor cell line (RT4). Overexpression of ncRAN in RT4 cells significantly enhanced cell proliferation, migration, and invasion. Silencing of ncRAN improved chemotherapy sensitivity in 5637 cells.

   Pubmed ID 21147498
   Year 2011
   Title ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival.
   External Links
   Links for  SNHG16 GenBank       HGNC       lncrnadb       Noncode
   Links for  bladder cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.